Page 4 - Decision Diagnostics News Today

/PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Decision...

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Decision Diagnostics Corporation ("Decision Diagnostics" or the...

SEC Acting Enforcement Director Marc P. Berger To Depart The Commission Date 12/01/2021 The Securities and Exchange Commission today announced that Marc P. Berger, Acting Director of the Division of Enforcement, will conclude his tenure at the agency this month. Mr. Berger joined the Commission as Director of the New York Regional Office in December 2017 and was named Deputy Director of the Division of Enforcement in August 2020. Under Mr. Bergers leadership, Enforcement staff pursued sign...

FOR IMMEDIATE RELEASE Washington D.C., Jan. 12, 2021 — The Securities and Exchange Commission today announced that Marc P. Berger, Acting Director of the Division of Enforcement, will conclude his tenure at the agency this month. Mr. Berger joined the Commission as Director of the New York Regional Office in December 2017 and was named Deputy Director of the Division of Enforcement in August 2020. Under Mr. Bergers leadership, Enforcement staff pursued significant cases ac...

During the time Berman is accused of defrauding investors, Decision Diagnostics’ stock rose by over 1,500%.

TMCnet News INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Decision Diagnostics Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm [December 28, 2020] INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Decision Diagnostics Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investig...

Details Written by IVN Washington, DC - The chief executive officer (CEO) of a California-based medical device company was indicted by a federal grand jury in connection with an alleged scheme to defraud investors by making false and misleading statements about the purported development of a new COVID-19 test, leading to millions of dollars in investor losses. Keith Berman, 67, the CEO of Decision Diagnostics Inc. (DECN), was charged by indictment, unsealed with one count ...

CEO Charged in Rapid COVID-19 Test Scam Decision Diagnostics’ stock soared 1,500% in less than two months on allegedly false claims of a 15-second COVID-19 test. The US Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) have charged the CEO of a California-based medical device company for allegedly leading a scheme to defraud investors out of millions of dollars by falsely claiming his company created a 15-second rapid COVID-19 test. Decision Diagnostics Inc. (DECN) ...

(2) The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test results it has amassed demonstrating the technologys promise LOS ANGELES, CA / ACCESSWIRE / December 21, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., as well as the des...

Home / Top News / SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Decision Diagnostics Corp. (DECN) and Encourages DECN Investors to Contact the Firm PHILADELPHIA, Dec. 19, 2020 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Decision Diagnostics Corp. (“Decision Diagnostics”) (OTC: DECN) on behalf of the comp...